Although non-steroidal anti-inflammatory drugs are known to cause peptic ulcer and its complications, controversy exists about the number of deaths from ulcer which are attributable totheir use. A case-control study was therefore performed to determine whether prior use of non-steroidal and other antiinflammatory compounds was associated with an increased case fatality rate from complications of peptic ulcer. Non-steroidal anti-inflammatory drugs were used by 39% of a series of 80 patients who had died from peptic ulcer complications and by 37% of 160 controls who were survivors matched for sex, age, ulcer site, and nature of complication (odds ratio 11; 95% confidence interval 0-6 to 2.1). Similarly, the rates of prior use of aspirin by cases and controls were almost identical (odds ratio 1-2; 95% confidence interval 0.5 to 1-9). Thus neither nonsteroidal anti-inflammatory drugs nor aspirin were associated with increased case fatality rates from peptic ulcer complications. In contrast, corticosteroids were associated with an increased mortality (odds ratio 4-2; 95% confidence interval 0-9 to . Although this increase in the estimated relative risk was not statistically significant, a review ofthe case records indicated that most deaths in steroid users were due to serious sepsis, indicating that there might be a causal association between use of the drugs and the mode of death.
Introduction
Non-steroidal anti-inflammatory drugs are among the most commonly prescribed drugs. They are often used to treat minor self limiting disorders, and any benefits of widespread use must be weighed carefully against the costs. Serious gastrointestinal toxicity, in particular bleeding or perforated peptic ulcer, is the most common side effect of these drugs that is reported voluntarily to national monitoring centres.' In determining risk spontaneous reports are of limited value, and formal epidemiological studies are necessary.
One measure of cost is the number of deaths directly attributable to the use of non-steroidal'anti-inflammatory drugs. In the United Kingdom published estimates have varied from 200 to over 3000 deaths each year.23 The higher estimate was based on an analysis of prior drug' use by patients who had died of bleeding or perforated ulcers.3 A fuller report from the same authors provided information on drug use by patients who died from, or required surgery for, complications of ulcer. 4 This report showed an unexpectedly high level of use of non-steroidal anti-inflammatory drugs by patients who died compared with those who survived, raising the possibility that the drugs increase not only the chance of developing ulcer complications but also the risk of dying of these disorders. An increase in case fatality rate might be due to a direct effect of the drugs-for example, on bleeding time or on renal function-or to a higher prevalence of other serious diseases among users of these drugs, making them more likely to fare badly after haemorrhage from, or perforation of, a peptic ulcer. The hypothesis of an increased case fatality rate was not supported by a multivariate analysis of factors determining the outcome after gastrointestinal bleeding, although that study included many patients without peptic ulcers and several who had bled while in hospital for other reasons.5
The controversy about the number of fatal peptic ulcer complications that can be attributed to non-steroidal anti-inflammatory drugs needs to be settled. We therefore conducted a case-control study to determine whether their use was associated with an increased case fatality rate from peptic ulcer complications in patients admitted to hospitals in Newcastle, New South Wales. This study also enabled us to examine the roles of aspirin and corticosteroids.
Subjects and methods
Since 1980 the Hunter health statistics unit has collected and stored information on all patients admitted to hospitals in the Hunter region ofNew South Wales. For each patient the information includes demographic data, the mode of discharge from hospital (died, discharged home, transferred, etc), and up to five discharge diagnoses. The greater Newcastle area has a population of about 390000 (1981 census) and is served by four public hospitals. Between January 1980 and June 1986, 1003 patients were admitted to these hospitals with a diagnosis of haemorrhage from, or perforation of, a peptic ulcer. The notes of all patients who had died during their hospital admission and whose records contained any mention ofpeptic ulcer complications in the discharge diagnoses were reviewed. Eighty one patients had died after admission to hospital with a primary diagnosis of complicated peptic ulcer (case fatality rate 8-1%). The case fatality rate was higher in patients aged over 60 (12-1%) and was higher after perforation (12-4%) than after haemorrhage (7 4%). Each fatal case was matched with two controls, who were patients who had survived a bleeding or perforated ulcer within two years of the case. Controls were matched with cases for age (to within five years), sex, site of ulcer (gastric or duodenal), and the nature ofthe complication (haemorrhage or perforation). The clinical notes from all cases and controls were examined to identify all drugs which had been taken during the week before admission to hospital. Although drug use was determined retrospectively, we thought it unlikely that this would introduce major bias in this study because ofdata we had already obtained from a casecontrol study with prospectively recruited patients with ulcers and controls without ulcers. In that study we had determined that information on the use of non-steroidal anti-inflammatory drugs and aspirin recorded in the hospital notes of 100 patients with ulcer complications admitted in 1985-6 was in 97% agreement with data obtained by structured interview and checked against the general practitioner's record. (D A Henry et al, 3rd international conference on pharmacoepidemiology, Minneapolis, 1987) .
The measure of association between exposure to the drugs of interest and mortality from ulcer complications was the odds ratio with its 95% confidence interval calculated for matched triplets by the method of Miettinen.' With 80 cases and 160 controls and a predicted prevalence ofuse of non-steroidal anti-inflammatory drugs of about 40% the study had a power ofapproximately 0 7 to detect as significant (a=0 05) a relative risk of 2-0 or above. This was considered sufficient to discriminate between the extremes of the published estimates of attributable mortality.
Results
Eighty patients who died from a bleeding or perforated ulcer were successfully matched for all variables. The average age of cases was 68-7 (range 40-90) years and of controls 68-3 (39-88) years; 71% of cases and controls were men, 44% had bleeding gastric ulcers, 25% bleeding duodenal ulcers, 21% perforated duodenal ulcers, and 10% perforated gastric ulcers.
There was no evidence that use of non-steroidal anti-inflammatory drugs was associated with an increased mortality from complications of peptic ulcer. On admission to hospital non-steroidal anti-inflammatory drugs were being taken by similar proportions of cases and controls and the odds ratio was close to 1. Likewise, therewas no evidence that aspirin use increased the this work not to alter the case fatality rate, suggest that each year about 170 cases and 16 deaths from ulcer complications are attributable to its use in New South Wales. This estimate is lower than for non-steroidal anti-inflammatory drugs because aspirin is regularly used less often by subjects in this age group in New South Wales (D A Henry et al, 3rd international conference on pharmacoepidemiology, Minneapolis, 1987) .
The suggestion that corticosteroids increase the case fatality rate from complications of peptic ulcer is a data derived hypothesis and should be interpreted with caution. Furthermore, the estimate of the relative risk is approximate because of small numbers. Nevertheless, the possibility ofa substantially increased case fatality rate for users of corticosteroids is supported by data from an extensive survey of gastrointestinal bleeding published by the American Society for Gastrointestinal Endoscopy.9 Interestingly, in our study the epidemiological data were backed by clinical evidence that the patients who died had suffered from adverse events which in some instances could be ascribed to the direct effect of corticosteroids, in particular overwhelming infections. Especially notable were two cases of staphylococcal septicaemia which were thought to be due to infection of intravenous cannula sites and thus by implication were preventable. On the basis of a meta-analysis of prospective randomised trials Messer et al concluded that corticosteroid treatment roughly doubled the incidence of haemorrhage from peptic ulcers.10 If our estimate of an increased fatality rate is correct then the risk of users of steroids developing and subsequently dying from ulcer complications might be about eight times higher than for non-users. Although this is a substantial increase for the individual, in population terms it is a small risk because of the low prevalence ofuse of steroids in the community.
Of the anti-inflammatory drugs, aspirin and non-steroidal antiinflammatory drugs, particularly the latter, are the important causes of morbidity and mortality in the community. Unlike steroids their intrinsic toxicity is not high. Rather, difficulties arise because of their extraordinarily wide use. Epidemiologically the relation is dominated by a high prevalence of the risk factor rather than a high relative risk of the disease. Thus the main thrust of attempts to reduce morbidity and mortality from non-steroidal anti-inflammatory drugs in the community should be to limit their use rather than to attempt to lower relative risk further by widespread coprescription of agents designed to "protect" the gastrointestinal mucosa, such as prostaglandins, sucralfate, or histamine H2 antagonists. While these measures may prove to have a role in a limited number of individuals, the greatest need is for more information on the factors which control prescribing decisions so that we can identify opportunities for intervention.
